Peak inspiratory flow rates through placebo dry powder inhaler device in various asthma and COPD patients Source: Annual Congress 2012 - Asthma management Year: 2012
Inspiratory flow rates at different levels of resistance in elderly COPD patients Source: Eur Respir J 2008; 31: 78-83 Year: 2008
Inhaler technique and peak inspiratory flow rates in patients with acute exacerbated COPD Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007
Peak inspiratory flow rates in COPD patients with Easyhaler® dry powder inhaler Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009
Peak inspiratory flow (PIF) when using a dry powder inhaler in asthmatics and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 99s Year: 2001
Peak inspiratory flow measured at different inhaler resistances in patients with asthma Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020
Inspiratory flow profiles of patients with severe COPD achieved through Autohaler, Diskus, Turbohaler and in vitro assessment of corresponding output characteristics Source: Eur Respir J 2003; 22: Suppl. 45, 409s Year: 2003
Low maximum inspiratory flow index in patients with inhaler therapy Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses Year: 2019
Evaluation of inspiratory flow rates in stable severe COPD patients Source: Annual Congress 2010 - Respiratory muscle function and training in acute and chronic respiratory disease Year: 2010
Analysis of peak inspiratory flow and use of dry powder inhalers in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019
Bronchodilator reversibility testing in COPD using an inspiratory peak flow meter Source: Annual Congress 2007 - Treatment of COPD Year: 2007
Sequential evaluation of expiratory flow limitation, inspiratory muscle strength and spirometry in severe COPD exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 149s Year: 2001
IPPB with temporary expiratory pressure (T-PEP) in surgical patients with COPD Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation Year: 2007
The maximum of expiratory cough pressure at the mouth (MECP-m) correlate with the cough peak expiratory flow (CPEF) and the degree of obstruction in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 623s Year: 2006
Effect of He-O2 breathing and inhaled salbutamol on expiratory flow limitation and dynamic hyperinflation in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 197s Year: 2002
The effect of tiotropium on exacerbations and airflow in patients with COPD Source: Eur Respir J 2006; 27: 547-555 Year: 2006
Improvements in inspiratory capacity with tiotropium in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 491s Year: 2002
Peak inspiratory flow in COPD: implications for the use of dry powder inhalers Source: Eur Respir J 2001; 18: Suppl. 33, 134s Year: 2001
Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV1 ) in patients with severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Respiratory structure and function Year: 2008
NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006